Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Brooks

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Plos Genetics|April 23, 2020
Drosophila NUAK functions with Starvin/BAG3 in autophagic protein turnoverDavid Brooks, Fawwaz Naeem, Marta Stetsiv, et al.
Zootaxa|September 12, 2022
Redescription of Wyeomyia (Decamyia) felicia (Dyar amp; Nez Tovar, 1927) and description of a new species of the subgenus from Trinidad (Diptera: Culicidae)Paulino Siqueira Ribeiro, Monique Albuquerque Motta, Giulia Caminha Seiblitz, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2014
Type I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infectionIvan Osokine, Laura M Snell, Cameron R Cunningham, et al.
Memorias Do Instituto Oswaldo Cruz|January 30, 2014
Mosquitoes of eastern Amazonian Ecuador: biodiversity, bionomics and barcodesYvonne-Marie Linton, James E Pecor, Charles H Porter, et al.
Journal of Parkinson'S Disease|August 14, 2013
Parkinson's disease--the debate on the clinical phenomenology, aetiology, pathology and pathogenesisPeter Jenner, Huw R Morris, Trevor W Robbins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2011
MK-1775, a potent Wee1 inhibitor, synergizes with gemcitabine to achieve tumor regressions, selectively in p53-deficient pancreatic cancer xenograftsN V Rajeshkumar, Elizabeth De Oliveira, Niki Ottenhof, et al.
Journal of Parkinson'S Disease|October 8, 2015
Anticholinergic Load: Is there a Cognitive Cost in Early Parkinson's Disease?Alison J Yarnall, Rachael A Lawson, Gordon W Duncan, et al.
Journal of the National Cancer Institute|May 1, 2008
Treating metastatic solid tumors with bortezomib and a tumor necrosis factor-related apoptosis-inducing ligand receptor agonist antibodyAnil Shanker, Alan David Brooks, Carlos Alberto Tristan, et al.
Frontiers in Oncology|September 3, 2019
Artificial Intelligence in the Management of Glioma: Era of Personalized MedicineHouman Sotoudeh, Omid Shafaat, Joshua D Bernstock, et al.
Cardiovascular Diabetology|March 5, 2025
A one-week reduced-carbohydrate diet to mitigate iatrogenic peripheral hyperinsulinemia does not improve insulin sensitivity or endothelial function in a randomized, crossover trial in patients with type 1 diabetesJustin M Gregory, T Jordan Smith, Sara H Duffus, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Plos Genetics|April 23, 2020
Drosophila NUAK functions with Starvin/BAG3 in autophagic protein turnoverDavid Brooks, Fawwaz Naeem, Marta Stetsiv, et al.
Zootaxa|September 12, 2022
Redescription of Wyeomyia (Decamyia) felicia (Dyar amp; Nez Tovar, 1927) and description of a new species of the subgenus from Trinidad (Diptera: Culicidae)Paulino Siqueira Ribeiro, Monique Albuquerque Motta, Giulia Caminha Seiblitz, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2014
Type I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infectionIvan Osokine, Laura M Snell, Cameron R Cunningham, et al.
Memorias Do Instituto Oswaldo Cruz|January 30, 2014
Mosquitoes of eastern Amazonian Ecuador: biodiversity, bionomics and barcodesYvonne-Marie Linton, James E Pecor, Charles H Porter, et al.
Journal of Parkinson'S Disease|August 14, 2013
Parkinson's disease--the debate on the clinical phenomenology, aetiology, pathology and pathogenesisPeter Jenner, Huw R Morris, Trevor W Robbins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2011
MK-1775, a potent Wee1 inhibitor, synergizes with gemcitabine to achieve tumor regressions, selectively in p53-deficient pancreatic cancer xenograftsN V Rajeshkumar, Elizabeth De Oliveira, Niki Ottenhof, et al.
Journal of Parkinson'S Disease|October 8, 2015
Anticholinergic Load: Is there a Cognitive Cost in Early Parkinson's Disease?Alison J Yarnall, Rachael A Lawson, Gordon W Duncan, et al.
Journal of the National Cancer Institute|May 1, 2008
Treating metastatic solid tumors with bortezomib and a tumor necrosis factor-related apoptosis-inducing ligand receptor agonist antibodyAnil Shanker, Alan David Brooks, Carlos Alberto Tristan, et al.
Frontiers in Oncology|September 3, 2019
Artificial Intelligence in the Management of Glioma: Era of Personalized MedicineHouman Sotoudeh, Omid Shafaat, Joshua D Bernstock, et al.
Cardiovascular Diabetology|March 5, 2025
A one-week reduced-carbohydrate diet to mitigate iatrogenic peripheral hyperinsulinemia does not improve insulin sensitivity or endothelial function in a randomized, crossover trial in patients with type 1 diabetesJustin M Gregory, T Jordan Smith, Sara H Duffus, et al.
Pageof 8